Published in Women's Health Weekly, November 14th, 2002
The cleared ACIS applications detect, measure, and quantify the presence of estrogen receptors and progesterone receptors (commonly referred to as ER/PR) at the cellular level, allowing physicians a more precise and quantitative understanding of the specific traits of individual cancer tumors. In this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.